07:32 AM EDT, 03/11/2024 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q4 loss Monday of $0.40 per diluted share, compared with a loss of $0.41 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.30.

Total revenue for the quarter ended Dec. 31 was $79.5 million, up from $27.6 million a year earlier.

Analysts surveyed by Capital IQ expected $95.7 million.

Shares of the company were up 2% in recent Monday premarket activity.

Price: 64.5, Change: +1.25, Percent Change: +1.98